Showcases Stock ranks Forex

Mylan N.V. (MYL)
15.73  -0.43 (-2.66%) 09-18 16:00
Open: 16.16 Pre. Close: 16.16
High: 16.19 Low: 15.61
Volume: 5,970,274 Market Cap: 8,132M
Mylan NV is a pharmaceutical healthcare company. The company is headquartered in Hatfield, Hertfordshire and currently employs 35,000 full-time employees. The firm develops, licenses, manufactures, markets and distributes generic, brand name and over-the-counter (OTC) products in a range of dosage forms and therapeutic categories. The company operates through three segments on a geographic basis, North America, Europe and Rest of World. The firm's Cold-EEZE family of brands includes OTC cold remedies sold as lozenges, gummies, oral sprays, caplets, QuickMelts and oral liquid dose forms in the United States. The North America segment primarily develops, manufactures, sells and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream or ointment form. The Europe segment sells pharmaceuticals under their International Nonproprietary Name (INN), such as active pharmaceutical ingredient (API), in certain European countries. The Rest of World segment is primarily made up of its operations in India, Australia, Japan and New Zealand.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 16.203 - 16.285 16.285 - 16.337
Low: 15.417 - 15.524 15.524 - 15.593
Close: 15.576 - 15.738 15.738 - 15.842
Stock Technical Analysis
Target: Six months: 18.99
One year: 19.89
Support: Support1: 15.02
Support2: 12.50
Resistance: Resistance1: 16.26
Resistance2: 17.03
Pivot: 15.73
Moving Averages: MA(5): 15.92
MA(20): 15.84
MA(100): 16.36
MA(250): 17.62
MACD: MACD(12,26): -0.11
Signal(12,26,9): -0.16
%K %D: %K(14,3): 63.31
%D(3): 63.30
RSI: RSI(14): 47.23
52-Week: High: 23.11
Low: 12.75
Change(%): -24.6
Average Vol(K): 3-Month: 502997
10-Days: 599803
Price, MAs and Bollinger Bands
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.

MYL has closed above bottom band by 49.9%. Bollinger Bands are 26.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Thu, 17 Sep 2020
Mylan/Pfizer's Upjohn Unit Merger on Track to Close in Q4 - Yahoo Finance

Wed, 16 Sep 2020
It’s Time to Buy the lift in Mylan N.V. [MYL] Stock -

Wed, 16 Sep 2020
Should You Buy Mylan NV (MYL) Stock Wednesday? - InvestorsObserver

Wed, 16 Sep 2020
Mylan N.V. (MYL) investors to reap big returns again - Marketing Sentinel

Wed, 16 Sep 2020
Mylan NV (NASDAQ:MYL) is Holding Steady - The Oracle Dispatch

Thu, 10 Sep 2020
Mylan NV (NASDAQ:MYL) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 516.95
Shares Float (M) 513.48
% Held by Insiders 1.37
% Held by Institutions 87.96
Shares Short (K) 44100
Shares Short Prior Month (K) 33900
Stock Financials
EPS 0.520
Book Value (p.s.) 22.720
Profit Margin 2.35
Operating Margin 15.22
Return on Assets (ttm) 3.5
Return on Equity (ttm) 2.3
Qtrly Rev. Growth -4.2
Gross Profit (p.s.) 8.802
Sales Per Share 22.246
EBITDA (p.s.) 6.751
Qtrly Earnings Growth
Operating Cash Flow (M) 1850.00
Levered Free Cash Flow (M) 2120.00
Stock Valuation
PE Ratio 30.25
PEG Ratio
Price to Book value 0.69
Price to Sales 0.71
Price to Cash Flow 4.40
Stock Dividends
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator